NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43 | +168.8% | 163,780 | +388.9% | 0.00% | – |
| Q2 2023 | $16 | -5.9% | 33,500 | +32.4% | 0.00% | – |
| Q1 2023 | $17 | -15.0% | 25,300 | +43.8% | 0.00% | – |
| Q4 2022 | $20 | -99.8% | 17,600 | +21.8% | 0.00% | – |
| Q3 2022 | $11,000 | -45.0% | 14,445 | -56.1% | 0.00% | – |
| Q2 2022 | $20,000 | -94.1% | 32,900 | -76.3% | 0.00% | – |
| Q1 2022 | $341,000 | – | 139,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $41,714 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 230,700 | $152,054 | 0.00% |
| Virtu Financial LLC | 46,210 | $30 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $12,062 | 0.00% |
| HBK Sorce Advisory LLC | 29,230 | $19,266 | 0.00% |
| UBS Group AG | 18,611 | $12,265 | 0.00% |
| NewEdge Advisors, LLC | 2,125 | $1,401 | 0.00% |
| OSAIC HOLDINGS, INC. | 27,225 | $17,933 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 30,000 | $19,770 | 0.00% |
| WELLS FARGO & COMPANY/MN | 5,309 | $3,500 | 0.00% |